Cargando…
Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
BACKGROUND: Immune checkpoint inhibition holds promise as a novel treatment for pancreatic ductal adenocarcinoma (PDAC). The clinical significance of soluble immune checkpoint (ICK) related proteins have not yet fully explored in PDAC. METHODS: We comprehensively profiled 14 soluble ICK-related prot...
Autores principales: | Pan, Sai, Zhao, Wenting, Li, Yizhan, Ying, Zhijun, Luo, Yihong, Wang, Qinchuan, Li, Xiawei, Lu, Wenjie, Dong, Xin, Wu, Yulian, Wu, Xifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225568/ https://www.ncbi.nlm.nih.gov/pubmed/37256126 http://dx.doi.org/10.3389/fimmu.2023.1189161 |
Ejemplares similares
-
Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer
por: Wang, Qinchuan, et al.
Publicado: (2022) -
Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
por: Wang, Qinchuan, et al.
Publicado: (2019) -
Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade
por: Gorgulho, Joao, et al.
Publicado: (2023) -
Editorial: Soluble immune checkpoints: Novel physiological immunomodulators
por: Riva, Antonio
Publicado: (2023) -
Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers
por: Li, Ye, et al.
Publicado: (2021)